CAMILLE COMBS: Open Payments
NPI 1841729530 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 37 payments from 11 companies in 2025. Trend: 2023 $1,505 · 2024 $634 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $383 |
| Axsome Therapeutics, Inc. | 7 | $372 |
| Lundbeck LLC | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Luye Pharma (USA) Ltd. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Alkermes, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, Auvelity, REXULTI, FANAPT, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, COBENFY, ARISTADA.
Industry payments across OH — which companies pay providers there.
